<i>Toxoplasma gondii</i> effector TgIST blocks type I interferon signaling to promote infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31413201.
- Also identified by DOI 10.1073/pnas.1904637116 and PMC identifier 6717281.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In contrast to the importance of type II interferon-γ (IFN-γ) in control of toxoplasmosis, the role of type I IFN is less clear. We demonstrate here that TgIST, a secreted effector previously implicated in blocking type II IFN-γ signaling, also blocked IFN-β responses by inhibiting STAT1/STAT2-mediated transcription in infected cells. Consistent with a role for type I IFN in cell intrinsic control, ∆<i>Tgis</i>t mutants were more susceptible to growth inhibition by murine and human macrophages activated with IFN-β. Additionally, type I IFN was important for production of IFN-γ by natural killer (NK) cells and recruitment of inflammatory monocytes at the site of infection. Mice lacking type I IFN receptors (Ifnar1<sup>-/-</sup>) showed increased mortality following infection with wild-type parasites and decreased virulence of ∆Tgist parasites was restored in Ifnar1<sup>-/-</sup> mice. The findings highlight the importance of type I IFN in control of toxoplasmosis and illuminate a parasite mechanism to counteract the effects of both type I and II IFN-mediated host defenses.
Medical subject headings
- Interferon Type I
- Protozoan Proteins
- Signal Transduction
- Toxoplasma
- Toxoplasmosis